171 related articles for article (PubMed ID: 33909473)
1. Racial Disparities in In-Hospital Adverse Events Among Patients With Atrial Fibrillation Implanted With a Watchman Left Atrial Appendage Occlusion Device: A US National Perspective.
Khan MZ; Munir MB; Darden D; Pasupula DK; Balla S; Han FT; Reeves R; Hsu JC
Circ Arrhythm Electrophysiol; 2021 May; 14(5):e009691. PubMed ID: 33909473
[TBL] [Abstract][Full Text] [Related]
2. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
[TBL] [Abstract][Full Text] [Related]
3. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
[TBL] [Abstract][Full Text] [Related]
4. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
[TBL] [Abstract][Full Text] [Related]
5. Acute Heart Failure Caused by Dislocation of a WATCHMAN Left Atrial Appendage Occluder.
Deng H; Liao H; Liu Y; Chen S; Xue Y; Zhan X; Fang X; Huang Y; Luo J; Fei H; Zhang Z; Wu S
JACC Cardiovasc Interv; 2016 May; 9(10):e97-9. PubMed ID: 27198691
[No Abstract] [Full Text] [Related]
6. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
7. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
[TBL] [Abstract][Full Text] [Related]
8. LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders.
Bergmann MW
Trends Cardiovasc Med; 2017 Aug; 27(6):435-446. PubMed ID: 28461140
[TBL] [Abstract][Full Text] [Related]
9. Incident Atrial Fibrillation Among American Indians in California.
Sanchez JM; Jolly SE; Dewland TA; Tseng ZH; Nah G; Vittinghoff E; Marcus GM
Circulation; 2019 Nov; 140(19):1605-1606. PubMed ID: 31630530
[No Abstract] [Full Text] [Related]
10. Asymptomatic dislocation of a Watchman left atrial appendage occluder.
Takayuki G; Grimmig O; Sören J; Dirk F
Asian Cardiovasc Thorac Ann; 2019 Jun; 27(5):394-395. PubMed ID: 30282462
[No Abstract] [Full Text] [Related]
11. Percutaneous Closure of Peridevice Leak After Left Atrial Appendage Occlusion.
Alkhouli M; Alqahtani F; Kazienko B; Olgers K; Sengupta PP
JACC Cardiovasc Interv; 2018 Jun; 11(11):e83-e85. PubMed ID: 29778732
[No Abstract] [Full Text] [Related]
12. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events.
Teiger E; Thambo JB; Defaye P; Hermida JS; Abbey S; Klug D; Juliard JM; Pasquie JL; Rioufol G; Lepillier A; Elbaz M; Horvilleur J; Brenot P; Pierre B; Le Corvoisier P;
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005841. PubMed ID: 29540492
[TBL] [Abstract][Full Text] [Related]
13. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
[TBL] [Abstract][Full Text] [Related]
14. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
[TBL] [Abstract][Full Text] [Related]
15. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
[TBL] [Abstract][Full Text] [Related]
16. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
17. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
18. Left-atrial-appendage occluder migrates in an asymptomatic patient.
Pisani P; Sandrelli L; Fabbrocini M; Tesler UF; Medici D
Tex Heart Inst J; 2014 Aug; 41(4):443-4. PubMed ID: 25120404
[TBL] [Abstract][Full Text] [Related]
19. Successful Percutaneous Retrieval of a 33-mm Watchman Left Atrial Appendage Occlusion Device From the Left Atrium.
Li HY; Wu XL; Xiao FY; Zhou XD; Chen Y; Huang WJ
JACC Cardiovasc Interv; 2018 Apr; 11(8):e65-e67. PubMed ID: 29454726
[No Abstract] [Full Text] [Related]
20. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.
Gloekler S; Shakir S; Doblies J; Khattab AA; Praz F; Guerios Ê; Koermendy D; Stortecky S; Pilgrim T; Buellesfeld L; Wenaweser P; Windecker S; Moschovitis A; Jaguszewski M; Landmesser U; Nietlispach F; Meier B
Clin Res Cardiol; 2015 Aug; 104(8):656-65. PubMed ID: 25736061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
